Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Feprazone

Home DrugsFeprazone

Experimental

Small Molecule

Feprazone

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Indications

用于风湿性关节炎、类风湿关节炎、肩周炎及牙痛。本品仅在其他非甾体抗炎药无效或无法使用时才可使用。

Technical identifiers

Chemical Formula: C₂₀H₂₀N₂O₂
CAS Number: 30748-29-9
UNII ID: 7BVX6J0CGR

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Preparation method of feprazone and intermediate of feprazone
Applicant: TIANJIN PACIFIC PHARMACEUTICALPriority: 2016
CN